Pricing Log in Create free account

20/20 Biolabs Inc. (AIDX) vs IceCure Medical Ltd. (ICCM)

20/20 Biolabs Inc. and IceCure Medical Ltd. are both Medical Devices companies. 20/20 Biolabs Inc. and IceCure Medical Ltd. are of similar size ($2.5M and $2.4M). 20/20 Biolabs Inc. has the higher net margin (−298.2% vs −570.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, 20/20 Biolabs Inc. leads on 9 and IceCure Medical Ltd. on 6.

Valuation

Metric AIDX ICCM Medical Devices median
P/E n/m n/m 24.94
P/S 0.99 0.62 2.66
P/B 1.33 0.14 2.36
Price to free cash flow n/m n/m 28.12
EV/EBITDA 0.39 0.67 11.42
EV/Sales (0.67) (3.79) 2.76
Earnings yield (436.45%) (895.94%) (12.66%)
Free cash flow yield (201.49%) (1,238.18%) (7.18%)

Profitability

Metric AIDX ICCM Medical Devices median
Gross margin 32.06% 28.13% 57.76%
Operating margin (198.15%) (574.61%) (14.84%)
Net margin (298.16%) (570.14%) (14.45%)
Free cash flow margin (200.12%) 0.00% (5.70%)
Return on equity 0.00% 0.00% (10.56%)
Return on assets (211.61%) 0.00% (17.26%)
Return on invested capital 0.00% 0.00% (5.22%)

Growth

Metric AIDX ICCM Medical Devices median
Revenue growth (TTM) — (41.07%) 10.41%
EPS growth (last fiscal year) 34.28% 20.00% 28.17%
Revenue growth, 5-year CAGR — (2.67%) 15.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AIDX ICCM Medical Devices median
Debt to equity 0.00 0.00 0.04
Current ratio 1.99 2.88 2.67
Net debt to EBITDA 0.11 0.60 0.54

Dividend

Metric AIDX ICCM Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.38

Size

Metric AIDX ICCM Medical Devices median
Market cap 2.50m 2.36m 221.84m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack